Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$351M |
| 2 |
Apple
AAPL
|
+$320M |
| 3 |
Chevron
CVX
|
+$295M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$240M |
| 5 |
ExxonMobil
XOM
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.21B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$417M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$404M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.88% |
| 2 | Financials | 5.4% |
| 3 | Healthcare | 5.17% |
| 4 | Communication Services | 4.22% |
| 5 | Consumer Discretionary | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNP
4751
DELISTED
Huaneng Power Intl, Inc.
HNP
| $197K | ﹤0.01% |
8,500
-660
| -7% | -$16.4K |
|
|
JCAP
4752
DELISTED
Jernigan Capital, Inc.
JCAP
| $196K | ﹤0.01% |
9,305
-5,794
| -38% | -$123K |
|
4753
Cardlytics
CDLX
$23.3M
| $195K | ﹤0.01% |
+1,179
| New | +$192K |
|
4754
Community Trust Bancorp
CTBI
$1.44B
| $195K | ﹤0.01% |
4,747
+3,709
| +357% | +$154K |
|
4755
Powell Industries
POWL
$7.7B
| $195K | ﹤0.01% |
22,023
+11,040
| +101% | +$109K |
|
|
PETQ
4756
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $195K | ﹤0.01% |
6,204
-32,505
| -84% | -$917K |
|
|
RUBY
4757
DELISTED
Rubius Therapeutics, Inc
RUBY
| $195K | ﹤0.01% |
10,831
+10,631
| +5,316% | +$163K |
|
|
OMN
4758
DELISTED
OMNOVA Solutions Inc.
OMN
| $195K | ﹤0.01% |
27,860
+8,861
| +47% | +$70.8K |
|
|
AVP
4759
PUT
DELISTED
Avon Products, Inc.
AVP
| $195K | ﹤0.01% |
66,300
-620,300
| -90% | -$1.56M |
|
|
GRA
4760
PUT
DELISTED
W.R. Grace & Co.
GRA
| $195K | ﹤0.01% |
2,500
-1,000
| -29% | -$73.7K |
|
4761
PUT
Puma Biotechnology
PBYI
$397M
| $194K | ﹤0.01% |
5,000
-4,600
| -48% | -$140K |
|
4762
CALL
SM Energy
SM
$7.44B
| $194K | ﹤0.01% |
11,100
-37,700
| -77% | -$670K |
|
|
WAIR
4763
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $194K | ﹤0.01% |
22,071
-37,217
| -63% | -$306K |
|
|
BPL
4764
PUT
DELISTED
Buckeye Partners, L.P.
BPL
| $194K | ﹤0.01% |
5,700
-11,900
| -68% | -$385K |
|
4765
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.4M
| $193K | ﹤0.01% |
560
+8
| +1% | +$3.27K |
|
|
RDFN
4766
PUT
DELISTED
Redfin
RDFN
| $193K | ﹤0.01% |
9,500
-1,000
| -10% | -$18.2K |
|
4767
Ennis
EBF
$565M
| $192K | ﹤0.01% |
9,241
+6,440
| +230% | +$133K |
|
|
GOOD
4768
Gladstone Commercial Corp
GOOD
$608M
| $192K | ﹤0.01% |
9,262
+8,193
| +766% | +$165K |
|
4769
Kopin
KOPN
$769M
| $192K | ﹤0.01% |
143,569
+15,470
| +12% | +$20.7K |
|
4770
CALL
Annaly Capital Management
NLY
$17.1B
| $192K | ﹤0.01% |
4,800
-23,100
| -83% | -$943K |
|
4771
CALL
Rockwell Medical
RMTI
$29.9M
| $192K | ﹤0.01% |
306
+154
| +101% | +$70.3K |
|
|
MODN
4772
DELISTED
MODEL N, INC.
MODN
| $192K | ﹤0.01% |
10,892
-10,854
| -50% | -$174K |
|
|
CBPO
4773
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $192K | ﹤0.01% |
+2,100
| New | +$172K |
|
4774
PUT
NCR Voyix
VYX
$1.22B
| $191K | ﹤0.01% |
11,410
+1,304
| +13% | +$21.6K |
|
|
CNCE
4775
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $191K | ﹤0.01% |
+15,800
| New | +$233K |
|
Similar funds
Barclays's Q1 2019 Portfolio in Review
As of Q1 2019, Barclays held 7,695 positions worth $145B, up 12% from $129B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays's Q1 2019 filing shows 645 new, 3,437 increased, 2,565 reduced and 541 closed positions. Its largest new stake was Fox Class B: 2,293,111 shares worth $82.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.53B.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 6.9% a quarter earlier, followed by Financials and Healthcare.
- Barclays's largest Q1 2019 buy was Fox Class B: 2,293,111 shares worth $82.3M.
- Barclays added most to State Street Communication Services Select Sector SPDR ETF in Q1 2019, an estimated $351M increase.
- Barclays's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.53B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2019, selling an estimated $1.21B.
- Barclays's ten largest holdings make up 30% of its $145B portfolio in Q1 2019.
- Barclays opened 645 new positions and closed 541 in Q1 2019.
- Barclays's portfolio value rose 12% quarter-over-quarter to $145B.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.